NASDAQ: NAGE
Niagen Bioscience Inc Stock Ownership - Who owns Niagen Bioscience?

Insider buying vs selling

Have Niagen Bioscience Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Robert N. FriedChief Executive Officer2025-04-0966,667$3.30
$220.00kBuy
Carlos Luis LopezSVP General Counsel2025-03-07273$7.86
$2.15kBuy
Frank L. Jaksch Jr.Director2024-12-1350,001$3.66
$183.00kBuy
Frank L. Jaksch Jr.Director2024-12-1337,161$6.19
$229.95kSell
Ozan PamirChief Financial Officer2024-11-222,907$7.36
$21.40kBuy
Kristin PatrickDirector2024-08-2323,000$3.57
$82.11kSell
Kristin PatrickDirector2024-08-2320,000$1.67
$33.40kBuy
Kristin PatrickDirector2024-08-233,000$1.64
$4.92kBuy

1 of 1

NAGE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NAGE insiders and whales buy or sell their stock.

NAGE Shareholders

What type of owners hold Niagen Bioscience Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Hoi Shuen Solina Holly Chau32.59%25,672,139$326.29MInsider
Barry C. Honig26.84%21,143,044$268.73MInsider
Champion River Ventures Ltd24.56%19,349,652$245.93MInsider
Michael Brauser19.32%15,219,914$193.45MInsider
Frank L. Jaksch Jr.18.10%14,260,386$181.25MInsider
Phillip Md Et Al Frost16.00%12,602,939$160.18MInsider
Tricia A. Jaksch7.90%6,225,155$79.12MInsider
Sheep Flp Black7.90%6,225,155$79.12MInsider
Margie Chassman5.60%4,408,640$56.03MInsider
Pioneer Step Holdings Ltd4.88%3,846,155$48.88MInsider

1 of 3

NAGE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NAGE15.04%84.96%Net BuyingNet Buying
VERV63.99%36.01%Net Selling
DYN79.63%20.37%Net SellingNet Selling
PHVS82.47%0.00%
ELVN45.09%54.91%Net SellingNet Selling

Niagen Bioscience Stock Ownership FAQ

Who owns Niagen Bioscience?

Niagen Bioscience (NASDAQ: NAGE) is owned by 31.61% institutional shareholders, 178.53% Niagen Bioscience insiders, and 0.00% retail investors. Hoi Shuen Solina Holly Chau is the largest individual Niagen Bioscience shareholder, owning 25.67M shares representing 32.59% of the company. Hoi Shuen Solina Holly Chau's Niagen Bioscience shares are currently valued at $326.29M.

If you're new to stock investing, here's how to buy Niagen Bioscience stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.